Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

At a time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical ...

The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...

Artificial intelligence (AI) is changing the way companies do business -- helping programmers write code and fielding ...

Artificial intelligence is changing the way industries do business. But executives in the pharmaceutical industry are still ...

After three years of mounting pressure from AIDS activists, the pharma companies finally dropped their case. While this story has a happy ending, Mandela’s battle against Big Pharma was only a ...

Hospitals account for about 30% of the $4.5 trillion the U.S. spends annually on healthcare, compared with 9% for drugs.

The last few years have been marked by many big pharma companies opting to move away from diversification and towards more focused operations. Ben Hargreaves explores what is driving this ...

The choice of outsourcing operating model(s) and the executive governance to implement the model(s) of choice are critical decisions for R&amp,D leadership teams in Big Pharma companies.